 |
 |

A significant and expanding resource for HSPH faculty who want assistance
in conducting cancer research is available in the Longwood Medical Area.
The Dana-Farber/Harvard Cancer Center (DF/HCC) helps cancer investigators
form collaborations and conduct research. The DF/HCC expanded the focus
of the Dana-Farber Cancer Center to encompass all Harvard cancer-related
research efforts. In 2000, the center received a five-year, $50 million
grant from the National Cancer Institute.
The center includes HSPH, Dana-Farber Cancer Institute, Harvard Medical
School (HMS), Beth Israel Deaconess Medical Center and the Brigham and
Womens, Childrens, and Massachusetts General Hospitals.
Membership is open to all HSPH and HMS faculty who are principal investigators
or project leaders on nationally peer-reviewed cancer-related research
grants; or are investigators participating in clinical cancer research
through protocol development and/or execution; or are newly independent
investigators at the instructor level or above engaged in cancer-related
research.
DF/HCC members have expertise in basic, clinical or population science.
Research is carried out in 16 "programs" divided according to
whether they are discipline-based, such as cancer imaging, or disease-based,
such as leukemia.
Other programs are in development.
The center also offers 19 "core facilities" that share resources
among members. For example, a DF/HCC member could be assigned a biostatistician
from the "Biostatistical Science Core," saving time and funding
by eliminating a search for a statistician.
"The DF/HCC offers the opportunity for people to make use of great
resources that can help cancer research and to belong to a group that
pulls people together from multiple disciplines so they can work on common
problems," said Nancy Mueller,
associate director for population science at DF/HCC and a professor in
the Department of Epidemiology at HSPH. "It just facilitates research
tremendously."
"What Can The "Population
Cores" Do For DF/HCC Members
Community
Practice Laboratory
Director: Suzanne Fletcher, MD
617-509-9975
Suzanne_fletcher@harvardpilgrim.org
The Community Practice Laboratory Core provides access to the members,
health care providers and computerized health-care information of members
of Harvard Pilgrim Health Care, the largest HMO in New England. The HMO
has approximately 770,000 members and 19,000 physicians. The core also
provides access to computerized medical records of Harvard Vanguard Medical
Associates. The core aids studies in real-life primary care and oncology
practices among patients across ages, ethnicities, risks and co-morbidities.
For each project, core staff will help investigators conduct preliminary
computer runs, contact personnel and plan logistics. They will also identify
a co-investigator at Harvard Pilgrim and assist with obtaining approval
for the project by the Office of Research Administration at the Department
of Ambulatory Care and Prevention.
Health
Communication
Director: Karen Emmons, PhD
617-632-2188
karen_emmons@dfci.harvard.edu
The Health Communication Core helps researchers inform, educate, recruit
and retain patients for research studies. The core offers consultations
on topics such as targeting an audience, planning and implementing focus
groups and developing marketing plans. In addition, the core offers services
such as writing, editing, graphic design and printing. The core can help
with something as simple as designing a single-page flyer or with something
as complex as developing and executing a comprehensive communication strategy,
including surveys and a full complement of promotional and educational
materials.
Measurement
Director: Laura Kubzansky, PhD
617-432-3589
lkubzans@hsph.harvard.edu
Core faculty offer free help in determining the advantages and disadvantages
of measurement tools at the study design phase, assisting in grant and
manuscript preparation and responding to reviewer comments on both grant
proposals and manuscripts. Advice is available on a wide range of measurement
issues, including clinical epidemiology, with a focus on clinical measurement;
physical activity and diet assessment; biomarkers; psychosocial measures;
geocoding; socioeconomic measures; and general survey methods.
Rapid
Case Identification Unit
Director: Nancy Mueller, ScD
617-432-4576
nmueller@hsph.harvard.edu
The Rapid Case Identification Unit supports epidemiological and clinical
research, including clinical trials by DF/HCC investigators. The unit
can provide rapid case identification for IRB-approved studies; provide
assistance with IRB approvals, medical records review, retrieval of pathology
specimens with appropriate approval; and identify population controls
from the greater Boston area.
Biostatistical Science
Director: David Harrington, PhD
617-632-2450
dph@hsph.harvard.edu
The Biostatistical Science Core offers expertise for the planning, conduct,
analysis and reporting of clinical trials; epidemiological- and population-based
studies; studies in the genetic susceptibility of cancer; and experiments
in basic research in cancer biology. The staff consults about database
design and management of clinical research data. The core also offers
computing for data analysis, scientific graphics and education about study
design, data collection and statistical methods.
High-Throughput Polymorphism Detection
Director: David Hunter, ScD
617-525-2755
david.hunter@channing.harvard.edu
The High-Throughput Polymorphism Detection Core helps investigators who
are conducting molecular analyses of germ-line and somatic DNA collected
as part of a population sciences investigation. This core provides high-throughput
assays of specific gene mutations and polymorphisms when specific nucleotide
alterations are of interest. The core offers polymorphism detection methods
that are accurate, are capable of daily sample throughputs in the range
of hundreds of samples, and can produce output in magnetically readable
form.
|
Core Facilities at
DF/HCC
Biostatistical Science
Breast Cancer
Cancer Pharmacology
Cell Manipulation
Community Practice Laboratory
Cytogenetics
Health Communication
Hematopathology
High-Throughput DNA Sequencing
High-Throughput Polymorphism Detection
In Situ Hybridization
Measurement
MSS Cryopreservation
Neuro-Oncology
Prostate
Protocol Review and Monitoring System
Rapid Case Identification Unit
Rodent Histopathology
Vector
Some Programs in Development at DF/HCC
AIDS-Related Malignancies
Angiogenesis, Invasion and Metastasis
Childhood Survivorship
Disparities in Cancer
GI Malignancies
Head and Neck Cancer
Lung
Melanoma and Cutaneous
Nursing
Palliative Care in Cancer
Radiation Biology/DNA Repair
Renal Cancer
Soft Tissue Sarcoma |
|
Programs
at DF/HCC
Biostatistics
Breast Cancer
Cancer Cell Biology
Cancer Epidemiology
Cancer Genetics
Cancer Imaging
Cancer Immunology
Experimental Therapeutics
GYN Cancer
Leukemia
Lymphoma
Neuro-Oncology
Outcomes Research
Prostate Cancer
Risk Reduction
Viral Oncology
|
For more information about DF/HCC, please contact Nancy Mueller at nmueller@hsph.harvard.edu. A web site is also available at
www.dfhcc.harvard.edu.
Harvard Public Health
NOW is published
biweekly by the
Office of Communications
Harvard School of Public Health
665 Huntington Ave., SPH 1-1204
Boston, Massachusetts 02115
617-432-6052
Editor and Layout: Christina Roache
Photos Credits: Richard
Chase, Christina Roache,
Dana-Farber/Harvard Cancer Center, Rachel Pescatore, Human
Resources, Photodisc, Inc., Dana-Farber Cancer Institute
Archived
Issues ||
HSPH Home
Copyright, 2009, President and Fellows of Harvard College
|